A pancancer analysis reveals the oncogenic role of glutaminase 1 (GLS1) in tumor metabolism and immune evasion: a bioinformatics analysis
Our study provides initial insights into the oncogenic roles of GLS1 across different tumors. These findings suggest that GLS1 can serve as a potential biomarker for determining prognosis and designing therapeutic strategies for various tumor types.
Authors
- Kangsheng Gu (ORCID: https://orcid.org/0009-0006-6961-1514)
- Shikai Hong
- Jianjun Liu (ORCID: https://orcid.org/0000-0001-5195-9535)
Institutions
- University of Science and Technology of China (CN)
- Anhui Medical University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1007/s12672-025-03779-3
- Citations
- 1
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- University of Science and Technology of China